RGD-targeted Proapoptotic Peptide (ACDCRGDCFC) proapoptotic peptide selectively binds αvβ3/αvβ5 integrins on tumor angiogenic endothelium, triggering apoptosis. Its disulfide-stabilized motif ensures serum stability and offers versatile conjugation sites for integrin-targeted ADCs, imaging agents, and precision therapeutics.
Usually ships within 24 hours.